Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ARS Pharmaceuticals - 5 Year Stock Price History | SPRY

Historical daily share price chart and data for ARS Pharmaceuticals since 2020 adjusted for splits and dividends. The latest closing stock price for ARS Pharmaceuticals as of June 26, 2025 is 18.08.
  • The all-time high ARS Pharmaceuticals stock closing price was 60.41 on March 17, 2021.
  • The ARS Pharmaceuticals 52-week high stock price is 18.51, which is 2.4% above the current share price.
  • The ARS Pharmaceuticals 52-week low stock price is 8.35, which is 53.8% below the current share price.
  • The average ARS Pharmaceuticals stock price for the last 52 weeks is 13.06.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
ARS Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 13.1738 10.7100 18.0800 10.1800 18.0800 71.37%
2024 10.6010 5.5800 17.4900 5.5000 10.5500 92.52%
2023 6.3099 8.4200 9.1100 2.9200 5.4800 -35.76%
2022 4.8218 6.7400 9.0300 2.9000 8.5300 28.08%
2021 27.7979 39.5400 60.4100 6.0300 6.6600 -85.63%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.695B $0.089B
ARS Pharmaceuticals Inc. is dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions which could lead to anaphylaxis. The company is developing neffy(TM) an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications and insect bites. ARS Pharmaceuticals Inc., formerly known as Silverback Therapeutics Inc., is based in SEATTLE.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.731B 32.16
Zoetis (ZTS) United States $70.000B 26.12
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Daiichi Sankyo, - (DSNKY) Japan $43.873B 22.49
BeOne Medicines - (ONC) Cayman Islands $29.277B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.324B 0.00
Merck (MKKGY) Germany $16.717B 12.25
Summit Therapeutics (SMMT) United States $15.797B 0.00
Shionogi (SGIOY) Japan $14.785B 14.81
United Therapeutics (UTHR) United States $12.899B 11.41
Neurocrine Biosciences (NBIX) United States $12.646B 43.31
Orion OYJ (ORINY) Finland $10.469B 28.31
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.846B 63.78
Stevanato Group S.p.A (STVN) Italy $7.647B 46.76
Ionis Pharmaceuticals (IONS) United States $6.366B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.165B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.851B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.323B 0.00
Hypermarcas (HYPMY) Brazil $2.977B 19.58
Crinetics Pharmaceuticals (CRNX) United States $2.847B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.627B 9.21
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.523B 13.64
NewAmsterdam Pharma (NAMS) Netherlands $2.058B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.038B 0.00
Indivior (INDV) United States $1.893B 8.03
Centessa Pharmaceuticals (CNTA) United Kingdom $1.794B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.464B 0.00
Guardian Pharmacy Services (GRDN) United States $1.285B 0.00
Dyne Therapeutics (DYN) United States $1.184B 0.00
Harrow (HROW) United States $1.157B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.085B 21.70
Enliven Therapeutics (ELVN) United States $1.055B 0.00
Verve Therapeutics (VERV) United States $0.999B 0.00
Akebia Therapeutics (AKBA) United States $0.967B 0.00
Collegium Pharmaceutical (COLL) United States $0.957B 5.16
Avadel Pharmaceuticals (AVDL) Ireland $0.913B 0.00
Ardelyx (ARDX) United States $0.869B 0.00
Elite Pharmaceuticals (ELTP) United States $0.816B 0.00
Xeris Biopharma Holdings (XERS) United States $0.737B 0.00
Cronos Group (CRON) Canada $0.729B 0.00
Altimmune (ALT) United States $0.625B 0.00
Liminatus Pharma (LIMN) United States $0.624B 0.00
Xencor (XNCR) United States $0.609B 0.00
KalVista Pharmaceuticals (KALV) United States $0.581B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.49
Regulus Therapeutics (RGLS) United States $0.565B 0.00
Relay Therapeutics (RLAY) United States $0.559B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.558B 0.00
Bioventus (BVS) United States $0.550B 13.94
Theravance Biopharma (TBPH) United States $0.529B 0.00
Zevra Therapeutics (ZVRA) United States $0.510B 0.00
AleAnna (ANNA) United States $0.483B 0.00
Siga Technologies (SIGA) United States $0.460B 9.61
Organogenesis (ORGO) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.436B 0.00
Oruka Therapeutics (ORKA) United States $0.435B 0.00
Savara (SVRA) United States $0.379B 0.00
Nektar Therapeutics (NKTR) United States $0.361B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 9.00
Heron Therapeutics (HRTX) United States $0.328B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nature's Sunshine Products (NATR) United States $0.274B 25.15
Tonix Pharmaceuticals Holding (TNXP) United States $0.250B 0.00
ProKidney (PROK) United States $0.226B 0.00
Nanobiotix S.A (NBTX) France $0.214B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Aldeyra Therapeutics (ALDX) United States $0.210B 0.00
Larimar Therapeutics (LRMR) United States $0.208B 0.00
OmniAb (OABI) United States $0.203B 0.00
Esperion Therapeutics (ESPR) United States $0.200B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.159B 0.00
Lexeo Therapeutics (LXEO) United States $0.139B 0.00
Lyell Immunopharma (LYEL) United States $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Avita Medical (RCEL) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.124B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Protara Therapeutics (TARA) United States $0.112B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 17.20
Arch Biopartners (ACHFF) Canada $0.091B 0.00
Cassava Sciences (SAVA) United States $0.089B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Vivani Medical (VANI) United States $0.077B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Telomir Pharmaceuticals (TELO) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Klotho Neurosciences (KLTO) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.038B 28.33
PolyPid (PYPD) Israel $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
FibroGen (FGEN) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Relmada Therapeutics (RLMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.22
Cosmos Health (COSM) United States $0.013B 0.00
Crescent Biopharma (CBIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00